Researchers Filed Patent for Woundra Dressing

North Carolina A&T State University developed a new plant-based wound care product to assist residents in rural areas.

Updated on Oct. 13, 2026 in Botany

Isometric editorial illustration of a cellulose-based medical patch and a natural fiber, representing new wound care technology.
Researchers at North Carolina A&T State University filed a provisional patent for Woundra, a plant-based hydrogel dressing designed for rural wound management. AI Illustration. Upload story photo >

Live Poll

Do you trust that new medical technology startups will effectively expand healthcare access in your community?

Researchers at North Carolina A&T State University in Greensboro have filed a provisional patent for Woundra, a plant-based wound dressing. The team also secured a $25,000 grant from NCInnovation to support the development of these cellulose-based hydrogels.

Why it matters

The development aims to provide reliable wound care for individuals in rural or farming communities who may lack immediate access to medical facilities. By integrating natural ingredients like Manuka honey and chitosan, the product offers a accessible alternative for wound management.

The researchers engineered cellulose-based hydrogels incorporated with polyvinyl alcohol to increase structural strength and flexibility. The design utilizes a combination of Manuka honey and chitosan to manage moisture and release antimicrobial treatments.

The players

North Carolina A&T State University

A public, historically Black research university located in Greensboro, North Carolina.

NCInnovation

An organization that supports applied research and commercialization efforts within the state of North Carolina.

Anthro Ventures

A firm that assists organizations in navigating complex federal regulatory landscapes.

EcoTrust

A collaborative partner working to develop efficient and cost-effective manufacturing methods.

The details

The research team partnered with EcoTrust to create low-cost manufacturing processes, with further regulatory guidance provided by Anthro Ventures. The product will eventually be available in multiple formats, including patches, foams, and ointments.

Timeline

  1. 9 to 15 months: Expected release of the over-the-counter hydrogel product.

  2. 35 months: Estimated total time for the FDA Class II medical device approval process.

The Big Picture

This project highlights the practical commercial output emerging from the North Carolina A&T State University agricultural and bioengineering research programs. It illustrates how university-led innovation is increasingly bridging the gap between laboratory science and rural healthcare delivery.

The potential commercialization of these dressings could provide residents with easier access to advanced antimicrobial wound care at home. If successfully brought to market, the product offers a lower-cost option for basic medical treatment outside of traditional clinics.

The takeaway

This development marks a significant step in using bio-based materials to address accessibility gaps in medical care. Readers should monitor for future regulatory updates as the team works toward clearing the FDA approval process.

Further reading

Learn more about local scientific advancements in the Botany section.

Source note: This article includes information reported by Thecharlottepost.

Live Poll

Do you trust that new medical technology startups will effectively expand healthcare access in your community?